Novel de novo SHANK3 mutation in autistic patients

Julie Gauthier; Dan Spiegelman; Amélie Piton; Ronald G. Lafreniére; Sandra Laurent; Judith St-Onge; Line Lapointe; Fadi F. Hamdan; Patrick Cossette; Laurent Mottron; Éric Fombonne; Ridha Joober; Claude Marineau; Pierre Drapeau; Guy A. Rouleau

doi:10.1002/ajmg.b.30822

Novel de novo SHANK3 mutation in autistic patients

Julie Gauthier, Dan Spiegelman, Amélie Piton, Ronald G. Lafreniére, Sandra Laurent, Judith St-Onge, Line Lapointe, Fadi F. Hamdan, Patrick Cossette, Laurent Mottron, Éric Fombonne, Ridha Joober, Claude Marineau, Pierre Drapeau, Guy A. Rouleau

Research output: Contribution to journal › Article › peer-review

274 Scopus citations

Abstract

A number of studies have confirmed that genetic factors play an important role in autism spectrum disorder (ASD). More recently de novo mutations in the SHANK3 gene, a synaptic scaffolding protein, have been associated with the ASD phenotype. As part of our gene discovery strategy, we sequenced the SHANK3 gene in a cohort of 427 ASD subjects and 190 controls. Here, we report the identification of two putative causative mutations: one being a de novo deletion at an intronic donor splice site and one missense transmitted from an epileptic father. We were able to confirm the deleterious effect of the splice site deletion by RT-PCR using mRNA extracted from cultured lymphoblastoid cells. The mis-sense mutation, a leucine to proline at amino acid position 68, is perfectly conserved across all species examined, and would be predicted to disrupt an alpha-helical domain. These results further support the role of SHANK3 gene disruption in the etiology of ASD.

Original language	English (US)
Pages (from-to)	421-424
Number of pages	4
Journal	American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume	150
Issue number	3
DOIs	https://doi.org/10.1002/ajmg.b.30822
State	Published - Apr 5 2009
Externally published	Yes

Keywords

Autism spectrum disorder
De novo
Pervasive developmental disorder
SHANK
Splice site

ASJC Scopus subject areas

Genetics(clinical)
Psychiatry and Mental health
Cellular and Molecular Neuroscience

Access to Document

10.1002/ajmg.b.30822

Cite this

Gauthier, J., Spiegelman, D., Piton, A., Lafreniére, R. G., Laurent, S., St-Onge, J., Lapointe, L., Hamdan, F. F., Cossette, P., Mottron, L., Fombonne, É., Joober, R., Marineau, C., Drapeau, P., & Rouleau, G. A. (2009). Novel de novo SHANK3 mutation in autistic patients. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 150(3), 421-424. https://doi.org/10.1002/ajmg.b.30822

Gauthier, J, Spiegelman, D, Piton, A, Lafreniére, RG, Laurent, S, St-Onge, J, Lapointe, L, Hamdan, FF, Cossette, P, Mottron, L, Fombonne, É, Joober, R, Marineau, C, Drapeau, P & Rouleau, GA 2009, 'Novel de novo SHANK3 mutation in autistic patients', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 150, no. 3, pp. 421-424. https://doi.org/10.1002/ajmg.b.30822

@article{a17151a6c7d546c5aae44f04d7205ee9,

title = "Novel de novo SHANK3 mutation in autistic patients",

abstract = "A number of studies have confirmed that genetic factors play an important role in autism spectrum disorder (ASD). More recently de novo mutations in the SHANK3 gene, a synaptic scaffolding protein, have been associated with the ASD phenotype. As part of our gene discovery strategy, we sequenced the SHANK3 gene in a cohort of 427 ASD subjects and 190 controls. Here, we report the identification of two putative causative mutations: one being a de novo deletion at an intronic donor splice site and one missense transmitted from an epileptic father. We were able to confirm the deleterious effect of the splice site deletion by RT-PCR using mRNA extracted from cultured lymphoblastoid cells. The mis-sense mutation, a leucine to proline at amino acid position 68, is perfectly conserved across all species examined, and would be predicted to disrupt an alpha-helical domain. These results further support the role of SHANK3 gene disruption in the etiology of ASD.",

keywords = "Autism spectrum disorder, De novo, Pervasive developmental disorder, SHANK, Splice site",

author = "Julie Gauthier and Dan Spiegelman and Am{\'e}lie Piton and Lafreni{\'e}re, {Ronald G.} and Sandra Laurent and Judith St-Onge and Line Lapointe and Hamdan, {Fadi F.} and Patrick Cossette and Laurent Mottron and {\'E}ric Fombonne and Ridha Joober and Claude Marineau and Pierre Drapeau and Rouleau, {Guy A.}",

year = "2009",

month = apr,

day = "5",

doi = "10.1002/ajmg.b.30822",

language = "English (US)",

volume = "150",

pages = "421--424",

journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",

issn = "1552-4841",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Novel de novo SHANK3 mutation in autistic patients

AU - Gauthier, Julie

AU - Spiegelman, Dan

AU - Piton, Amélie

AU - Lafreniére, Ronald G.

AU - Laurent, Sandra

AU - St-Onge, Judith

AU - Lapointe, Line

AU - Hamdan, Fadi F.

AU - Cossette, Patrick

AU - Mottron, Laurent

AU - Fombonne, Éric

AU - Joober, Ridha

AU - Marineau, Claude

AU - Drapeau, Pierre

AU - Rouleau, Guy A.

PY - 2009/4/5

Y1 - 2009/4/5

N2 - A number of studies have confirmed that genetic factors play an important role in autism spectrum disorder (ASD). More recently de novo mutations in the SHANK3 gene, a synaptic scaffolding protein, have been associated with the ASD phenotype. As part of our gene discovery strategy, we sequenced the SHANK3 gene in a cohort of 427 ASD subjects and 190 controls. Here, we report the identification of two putative causative mutations: one being a de novo deletion at an intronic donor splice site and one missense transmitted from an epileptic father. We were able to confirm the deleterious effect of the splice site deletion by RT-PCR using mRNA extracted from cultured lymphoblastoid cells. The mis-sense mutation, a leucine to proline at amino acid position 68, is perfectly conserved across all species examined, and would be predicted to disrupt an alpha-helical domain. These results further support the role of SHANK3 gene disruption in the etiology of ASD.

AB - A number of studies have confirmed that genetic factors play an important role in autism spectrum disorder (ASD). More recently de novo mutations in the SHANK3 gene, a synaptic scaffolding protein, have been associated with the ASD phenotype. As part of our gene discovery strategy, we sequenced the SHANK3 gene in a cohort of 427 ASD subjects and 190 controls. Here, we report the identification of two putative causative mutations: one being a de novo deletion at an intronic donor splice site and one missense transmitted from an epileptic father. We were able to confirm the deleterious effect of the splice site deletion by RT-PCR using mRNA extracted from cultured lymphoblastoid cells. The mis-sense mutation, a leucine to proline at amino acid position 68, is perfectly conserved across all species examined, and would be predicted to disrupt an alpha-helical domain. These results further support the role of SHANK3 gene disruption in the etiology of ASD.

KW - Autism spectrum disorder

KW - De novo

KW - Pervasive developmental disorder

KW - SHANK

KW - Splice site

UR - http://www.scopus.com/inward/record.url?scp=63449111560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63449111560&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30822

DO - 10.1002/ajmg.b.30822

M3 - Article

C2 - 18615476

AN - SCOPUS:63449111560

SN - 1552-4841

VL - 150

SP - 421

EP - 424

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

IS - 3

ER -

Novel de novo SHANK3 mutation in autistic patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this